Curanex Pharmaceuticals Inc Common Stock (CURX) is a publicly traded the market company. As of October 19, 2026, CURX trades at $4.92 with a market cap of $7.25M and a P/E ratio of -30.85. CURX moved +0.00% today. Year to date, CURX is -25.59%; over the trailing twelve months it is -64.61%. Its 52-week range spans $3.58 to $183.59. Rallies surfaces CURX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Curanex faces two IPO disclosure suits, with response deadlines extended: Curanex Pharmaceuticals faces two proposed securities class actions over disclosures tied to its August 2025 IPO. Filings say response deadlines for the Morales and Lovett complaints were extended to November 15 and December 11, 2026, respectively.
| Metric | Value |
|---|---|
| Price | $4.92 |
| Market Cap | $7.25M |
| P/E Ratio | -30.85 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $183.59 |
| 52-Week Low | $3.58 |
| Volume | 6.51K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-4.23M |
| Gross Margin | 0.00% |
CURX analyst coverage data. Average price target: $0.00.